Literature DB >> 12921154

Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis.

I Yuksekol1, M Ozkan, O Akgul, E Tozkoparan, M Al-Rashed, A Balkan, K Hatipoglu, H Bilgic, K Erbil, N Demirci.   

Abstract

SETTING: Pulmonary department of a university hospital in Ankara, Turkey.
OBJECTIVE: To investigate the usefulness of neopterin in pulmonary tuberculosis (PTB) as a rapid diagnostic tool.
DESIGN: Neopterin concentrations in bronchoalveolar lavage fluid (BAL), serum and urine were measured in patients with PTB, with lung cancer and with pneumonia and in a healthy control group.
RESULTS: In the BAL of PTB patients, serum and urine levels of neopterin were significantly higher than all the other groups (P < 0.001). Compared with the lung cancer group, PTB patients had higher neopterin in BAL and urine (P < 0.05). The PTB group had higher levels not only in BAL and urine, but also in serum, than the pneumonia group (P < 0.05). Compared with the pneumonia group and the healthy controls, neopterin levels in serum and urine were significantly higher in the lung cancer group (P < 0.05). In the PTB group, patients with moderately advanced PTB according to radiographic extent had higher levels of urine neopterin than patients with minimal disease (P = 0.01).
CONCLUSION: Neopterin levels in BAL, serum and particularly in urine may reflect PTB activity before exact diagnosis of the disease by culture results, and correlates with radiological extent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921154

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

Review 1.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

2.  IP-10 detection in urine is associated with lung diseases.

Authors:  Angela Cannas; Ludovica Calvo; Teresa Chiacchio; Gilda Cuzzi; Valentina Vanini; Francesco N Lauria; Luigia Pucci; Enrico Girardi; Delia Goletti
Journal:  BMC Infect Dis       Date:  2010-11-22       Impact factor: 3.090

Review 3.  Neopterin in Diagnosis and Monitoring of Infectious Diseases.

Authors:  Michael Eisenhut
Journal:  J Biomark       Date:  2013-12-08

4.  Determination of Urinary Neopterin/Creatinine Ratio to Distinguish Active Tuberculosis from Latent Mycobacterium tuberculosis Infection.

Authors:  Michael Eisenhut; Dougal S Hargreaves; Anne Scott; David Housley; Andrew Walters; Rohinton Mulla
Journal:  J Biomark       Date:  2016-06-28

5.  Comparison between plasma neopterin and the urine neopterin:creatinine ratio as inflammatory biomarkers.

Authors:  Bianca Thomas; Priyesh Bipath; Margaretha Viljoen
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

6.  Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis.

Authors:  Flonza Isa; Sean Collins; Myung Hee Lee; Diessy Decome; Nancy Dorvil; Patrice Joseph; Lauren Smith; Stephen Salerno; Martin T Wells; Steven Fischer; James M Bean; Jean W Pape; Warren D Johnson; Daniel W Fitzgerald; Kyu Y Rhee
Journal:  EBioMedicine       Date:  2018-04-22       Impact factor: 8.143

7.  Comparison of serum neopterin levels in pulmonary tuberculosis patients with positive acid fast bacilli and inactive pulmonary tuberculosis.

Authors:  Soedarsono Soedarsono; Parluhutan Dolli
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.